FEATURED SEARCH TERM: clear cell
A prognostic score based on assessing inflammation by combining C-reactive protein and albumin levels in patients with clear cell kidney cancer proves at least as good as other methods of determining cancer-specific survival, according to this prospective study. The algorithm is simple and based on protein assays that are well standardized and widely available.
RESULT: Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
British Journal of Cancer | Dec 13, 2011 (Free abstract. Full text $32)
As to less simple and widely available tests, authors from the Cleveland Clinic describe the new use of single nucleotide polymorphisms (SNPs) to determine prognosis and appropriate use of sutinib among patients with renal clear cell carcinoma.
RESULT : Predicting responses to sunitinib using single nucleotide polymorphisms: Progress and recommendations for future trials
Genome Medicine | Dec 30, 2011 (Free abstract. Full text $51.50)
TopicIndex
MostPopular
|
|
